Ford Financial Group’s Biogen BIIB Stock Holding History

Ford Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8	Closed	-$2K	–	158
2021 Q2	$2K	Buy	+8	New	+$2.42K	﹤0.01%	463
2018 Q1	–	Sell	-38	Closed	-$12K	–	85
2017 Q4	$12K	Buy	+38	New	+$12.2K	0.01%	192

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ford Financial Group's BIIB Position: Q3 2021 in Review

Ford Financial Group sold out of Biogen (BIIB) in Q3 2021, closing a stake of 8 shares — an estimated $2K sold.

Ford Financial Group first reported a position in BIIB in Q4 2017 and held it in 2 quarters. The position peaked at $12K in Q4 2017. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Ford Financial Group reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
Ford Financial Group sold 8 Biogen shares in Q3 2021, an estimated $2K.
Ford Financial Group first reported a position in Biogen in Q4 2017 and held it in 2 quarters.
Ford Financial Group's Biogen position peaked at $12K in Q4 2017.
1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Ford Financial Group's 13F filing for Q3 2021, filed 5 Nov 2021.